Type(s) of Cancer
Neuroendocrine
Neuroendocrine
Study Phase
Phase 3
Study Completion Date
January 2015
January 2015
NCT00569127Uploaded 02-24-2018
Access via NCI by Request
PDS UID: nci-data-371
Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients
Files: NCT00569127-D2
Data DictionaryNCT00569127-D2-Data-Dictionary.pdf
DATANCT00569127-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00569127-D1
Data DictionaryNCT00569127-D1-Data-Dictionary.pdf
DATANCT00569127-D1-Dataset.csv
OTHERREADME.pdf